​

Alaunos Therapeutics (TCRT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

TCRT Stock Rating

Alaunos Therapeutics stock's rating consensus is Hold, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (10.00%), 8 Hold (80.00%), 1 Sell (10.00%), and 0 Strong Sell (0.00%).

Hold
Total 10 0 1 8 1 Strong Sell Sell Hold Buy Strong Buy

TCRT Price Target Upside V Benchmarks

TypeNameUpside
StockAlaunos Therapeutics-
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.69$2.69$2.69
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 24--1--1
Oct, 24--1--1
Sep, 24--1--1
Aug, 24--1--1
Jul, 24--1--1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 15, 2023H.C. WainwrightBuyupgrade

Financial Forecast

EPS Forecast

$-60 $-49 $-38 $-27 $-16 $-5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-53.80$-25.97$-21.97----
Avg Forecast$-59.47$-26.75$-22.50$-6.00$-19.50$-21.00$-18.00
High Forecast$-59.47$-26.75$-22.50$-6.00$-19.50$-21.00$-18.00
Low Forecast$-59.47$-26.75$-22.50$-6.00$-19.50$-21.00$-18.00
Surprise %-9.53%-2.92%-2.36%----

Revenue Forecast

$0 $120M $240M $360M $480M $600M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$398.00K$2.92M$5.00K$10.00K---
Avg Forecast$399.33K$2.92M$4.00K$5.00K$556.93M$87.53M$220.41M
High Forecast$399.33K$2.92M$4.00K$5.00K$556.93M$87.53M$220.41M
Low Forecast$399.33K$2.92M$4.00K$5.00K$556.93M$87.53M$220.41M
Surprise %-0.33%0.12%25.00%99.92%---

Net Income Forecast

$-1B $-800M $-600M $-400M $-200M $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-76.89M$-37.60M$-35.14M$-4.68M---
Avg Forecast$-951.26M$-42.79M$-35.99M$-9.60M$-31.19M$-33.59M$-28.79M
High Forecast$-951.26M$-42.79M$-35.99M$-9.60M$-31.19M$-33.59M$-28.79M
Low Forecast$-951.26M$-42.79M$-35.99M$-9.60M$-31.19M$-33.59M$-28.79M
Surprise %-91.92%-12.13%-2.36%-51.25%---

TCRT Forecast FAQ

Is Alaunos Therapeutics stock a buy?

Alaunos Therapeutics stock has a consensus rating of Hold, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 8 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Alaunos Therapeutics is a neutral investment for most analysts.

What is Alaunos Therapeutics's price target?

Alaunos Therapeutics's price target, set by 10 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $2.69.

How does Alaunos Therapeutics stock forecast compare to its benchmarks?

Alaunos Therapeutics's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Alaunos Therapeutics over the past three months?

  • November 2024: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • October 2024: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2024: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Alaunos Therapeutics’s EPS forecast?

Alaunos Therapeutics's average annual EPS forecast for its fiscal year ending in December 2025 is $-19.5, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $-21 in 2026, and $-18 in 2027.

What is Alaunos Therapeutics’s revenue forecast?

Alaunos Therapeutics's average annual revenue forecast for its fiscal year ending in December 2025 is $556.93M, reflecting a 5569160.00% increase from the reported $10K in 2024. The forecast for 2026 is $87.53M, and $220.41M for 2027.

What is Alaunos Therapeutics’s net income forecast?

Alaunos Therapeutics's net income forecast for the fiscal year ending in December 2025 stands at $-31.191M, representing an 566.61% increase from the reported $-4.679M in 2024. Projections indicate $-33.59M in 2026, and $-28.791M in 2027.